Oral antioxidants may delay geographic atrophy in AMD patients, finds study
A new study published in the journal of Ophthalmology suggests that supplementing with oral micronutrients reduced the development of geographic atrophy (GA) into the central macula, most likely by enhancing the innate foveal sparing effect. The only authorized therapies for age-related macular degeneration (AMD) that reduce the course of geographic atrophy are expensive and have significant risks with requirement for repeated intraocular injections. Thus, Tiarnan Keenan and colleagues wanted to find out if oral supplements can reduce the advancement of GA in AMD.
The Age-Related Eye Diseases Study (AREDS) and AREDS2 were multi-center randomized controlled trials with a 2x2 factorial design and placebo control which underwent post hoc analysis. In AREDS, 392 eyes (318 participants) had GA, but in AREDS2, 1210 eyes (891 participants) had GA. The oral antioxidants (400 IU vitamin E, 500 mg vitamin C, 15 mg β-carotene), 80 mg zinc, combination, or placebo were given at random to AREDS participants. The participants of AREDS2 were randomized to receive a placebo, 350 mg of docosahexaenoic acid/650 mg of eicosapentaenoic acid, 10 mg of lutein/2 mg of zeaxanthin, or a combination. The consented participants in AREDS2 were additionally randomized to one of three alternative AREDS formulations being, original, without beta-carotene, with 25 mg of zinc instead of 80 mg, or both.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.